A double-blind, randomized, multicenter, controlled study to evaluate the immunogenicity, safety, and tolerability of varicella vaccine (VARIVAX™) passage extension 34 (PE34) process administered concomitantly with measles, mumps, and rubella vaccine (M-M-R™ II)

A double-blind, randomized, multicenter, controlled study to evaluate the immunogenicity, safety, and tolerability of varicella vaccine (VARIVAX™) passage extension 34 (PE34) process administered concomitantly with measles, mumps, and rubella vaccine (M-M-R™ II)

The varicella vaccine passage extension (VAR-PE) process was undertaken to extend the availability of varicella zoster virus (VZV)-containing vaccines. This study (V210-A03; NCT03239873) assessed the immunogenicity, safety, and tolerability of VAR-PE process in comparison with varicella vaccine comm...

Full description

Bibliographic Details
Main Authors: Peter E. Silas, Edward N. Zissman, Julie Gardner, Shanjun Helian, Andrew W. Lee, Heather L. Platt
Format: Article
Language:English
Published: Taylor & Francis Group 2020-11-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
varicella
safety
immunogenicity
measles
mumps
rubella
Online Access:http://dx.doi.org/10.1080/21645515.2020.1743122

Internet

http://dx.doi.org/10.1080/21645515.2020.1743122

Similar Items